Treatment(s) already received-Chemotherapy Posts on Medivizor
Navigation Menu

Treatment(s) already received-Chemotherapy Posts on Medivizor

Searching for patients with lung cancer that cannot be operated on to test durvalumab after chemotherapy and radiation

Posted by on Jun 24, 2019 in Lung cancer | 0 comments

In a nutshell This phase 2 trial will investigate the safety and effectiveness of durvalumab (Imfinzi) in patients with stage III non-small cell lung cancer (NSCLC).  The main outcomes will be the number of treatment-related adverse events (TRAEs) and progression-free survival (PFS).  The details Non-small cell lung cancer (NSCLC)...

Read More

PET scans in determining outcomes for patients with Hodgkin lymphoma treated with chemotherapy

Posted by on May 20, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study aimed to investigate the role of positron emission tomography (PET; an imaging technique) in determining the outcomes for patients with Hodgkin lymphoma treated with chemotherapy. This study concluded that negative-PET scans after chemotherapy predict good outcomes for these patients, regardless of stage at...

Read More

Searching for patients with non-small cell lung cancer to trial a new targeted therapy drug

Posted by on May 11, 2019 in Lung cancer | 0 comments

In a nutshell This phase 3 trial will investigate the safety and effectiveness of osimertinib (Tagrisso) after chemoradiation (CR) in non-small cell lung cancer (NSCLC). The main outcome will be progression-free survival (PFS; survival without cancer growing or spreading). The details Non-small cell lung cancer (NSCLC) is the most...

Read More

Searching for patients to try a new combination of treatments for relapsed or unresponsive Hodgkin lymphoma.

Posted by on Apr 22, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study will investigate the effects of pembrolizumab (Keytruda) and targeted radiation therapy for relapsed or unresponsive Hodgkin lymphoma (HL). This study will measure the rate of complete response (disappearance of all cancer). The details Many patients are cured with treatments for HL. Some patients lose response to...

Read More

Looking for patients advanced colorectal cancer to test a new treatment and a predictive blood test

Posted by on Apr 17, 2019 in Colorectal cancer | 0 comments

In a nutshell This trial is examining the effectiveness of circulating cell-free tumor DNA (cCFTD) as a predictive factor for the treatment of advanced colorectal cancer with regorafenib (Stivarga) or TAS-102. The main outcome to be measured will be to evaluate the ability of early change of cCFTD after the start of the treatment. This trial will be...

Read More

Consolidation chemotherapy before surgery improves the outcomes in advanced rectal cancer.

Posted by on Mar 29, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness and safety of consolidation chemotherapy after initial treatment in locally advanced rectal cancer. Researchers suggested that this treatment is safe and is associated with improved cancer outcomes.  Some background Colorectal cancer is the fifth most common cancer. From all the colorectal...

Read More

The use of brentuximab vedotin before transplant for patients with Hodgkin’s lymphoma

Posted by on Mar 29, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study aimed to compare outcomes for patients with Hodgkin’s lymphoma who received brentuximab vedotin (Adcetris) compared to chemotherapy before a stem cell transplant. This study concluded that patients who received brentuximab vedotin had a better survival. Some background Allogeneic hematopoietic stem cell...

Read More

Looking for participants to test the effectiveness and safety of vicriviroc in the treatment of advanced colorectal cancer

Posted by on Mar 12, 2019 in Colorectal cancer | 0 comments

In a nutshell This trial is examining the effectiveness and safety of vicriviroc (VIC) plus pembrolizumab (Keytruda) in the treatment of advanced colorectal cancer. The main outcome to be measured is the tumor response to treatment. This trial is being conducted in the US and Canada.   The details Colorectal cancer is the third most common...

Read More

Looking for patients with relapsed or refractory lymphoma to test a cell therapy

Posted by on Feb 28, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This phase 1 trial is investigating the effectiveness and safety of a new T-cell therapy for relapsed or unresponsive lymphoma. The main outcome to be measured will be the side effects of treatment and long-term survival. This study is being conducted in Chapel Hill, North Carolina, United States. The details In cancer therapy,...

Read More

Looking for men with castration-resistant prostate cancer to try 177Lu-PSMA-617

Posted by on Feb 24, 2019 in Prostate cancer | 0 comments

In a nutshell This trial is looking at the effectiveness of 177Lu-PSMA-617 in the treatment of castration-resistant (tumor grows even with hormone therapy) prostate cancer. The main outcome to be measured is overall survival.  The details Prostate cancer is an uncontrolled growth of the cells which make up the prostate gland. Prostate...

Read More